|
Market Closed -
Deutsche Boerse AG
13:11:52 02/10/2026 +04
|
After hours 00:03:10 | |||
| 5.100 EUR | -1.92% |
|
5.150 | +0.98% |
Company Valuation: MEDICLIN AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 186.2 | 171 | 130.2 | 115 | 175.8 | 242.2 | - | - |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 37.84% | - | - |
| Enterprise Value (EV) | 186.2 | 171 | 130.2 | 115 | 175.8 | 242.2 | 242.2 | 242.2 |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 37.84% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | 1.02x | 0.82x | 0.66x | 0.52x | 0.71x | 0.85x | 0.76x | 0.67x |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.28x | 0.24x | 0.18x | 0.15x | 0.22x | 0.31x | 0.3x | 0.3x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.31x | 0.3x | 0.3x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 2.12x | 2.1x | 2.1x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 3.9x | 3.88x | 3.86x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | - | - | - | - | 1.08% | 0.78% | 0.78% | 0.78% |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 673.1 | 704.7 | 730.1 | 748.8 | 784.5 | 787.5 | 803.2 | 819.3 |
| EBITDA 1 | 85.22 | 90.92 | 98.73 | 103.8 | 115.6 | 114.3 | 115.3 | 115.6 |
| EBIT 1 | 11.56 | 19.52 | 12.72 | 53.49 | 55.36 | 62.11 | 62.47 | 62.72 |
| Net income 1 | 1.461 | 9.441 | -10.78 | 24.84 | 25.49 | 36.66 | 38.2 | 40.12 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.920 | 3.600 | 2.740 | 2.420 | 3.700 | 5.100 | 5.100 | 5.100 |
| Nbr of stocks (in thousands) | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | - | - |
| Announcement Date | 30/03/22 | 31/03/23 | 27/03/24 | 28/03/25 | 27/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.4x | 0.39x | 8.06x | 3.12% | 109B | ||
| 14.3x | 1.8x | 9x | 0.73% | 91.66B | ||
| -292.81x | 19.87x | -343.85x | -.--% | 58.88B | ||
| 13.37x | 1.47x | 8.89x | 2.67% | 27.78B | ||
| 22.74x | 2.54x | 12.9x | 1.43% | 25.51B | ||
| 21.86x | 2.02x | 11.6x | 0.96% | 24.7B | ||
| 30.99x | 5.59x | 23.23x | 2.25% | 20.99B | ||
| 7.71x | 1.4x | 6.37x | -.--% | 20.45B | ||
| 30.1x | 2.82x | 12.71x | 1.49% | 16.65B | ||
| Average | -15.48x | 4.21x | -27.90x | 1.41% | 43.95B | |
| Weighted average by Cap. | -29.77x | 4.36x | -42.60x | 1.55% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MED Stock
- MED Stock
- Valuation MEDICLIN AG
Select your edition
All financial news and data tailored to specific country editions
















